A New Chapter in the Management of Hypertrophic Cardiomyopathy Cardiac Myosin Inhibitors /

In the recent years, there has been a significant breakthrough in the treatment of hypertrophic cardiomyopathy. New precision molecules have been developed and successfully applied in clinical trials. A new class of orally available allosteric inhibitors reduces heart muscle hypercontractility, the...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Pálinkás Eszter Dalma
Sepp Róbert
Olivotto Iacopo
Dokumentumtípus: Cikk
Megjelent: 2023
Sorozat:CARDIOLOGIA HUNGARICA 53 No. 4
Tárgyszavak:
doi:10.26430/CHUNGARICA.2023.53.4.337

mtmt:34154906
Online Access:http://publicatio.bibl.u-szeged.hu/28333

Hasonló tételek